Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United States/Eloralintide
Purchase and availability checkEloralintide in the United States

Can you buy Eloralintide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Eloralintide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United States
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Eloralintide in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Eloralintide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Eloralintide in United States?

Resolve the exact identity of Eloralintide through Eloralintide Phase 2 study - NCT06230523 from ClinicalTrials.gov. Then search Drugs@FDA approved drug database from U.S. Food and Drug Administration for the destination product record and Locate a state-licensed online pharmacy from U.S. Food and Drug Administration for the seller, establishment, or supply route in United States. A match in one record does not replace the other two checks.

03

Does an online listing prove Eloralintide is authorized or available in United States?

No. A page using the name Eloralintide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United States, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Eloralintide clinical trials in United States

16 study records currently list 443 locations in this country, including 322 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
16
Listed locations
443
Recruiting locations
322
Records with local recruiting sites
10
NCT06143956
Study-wide statusRecruiting

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Listed locations
50
Recruiting locations
43
Registry update
2026-07-20
NCT07215559
Study-wide statusRecruiting

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Listed locations
26
Recruiting locations
26
Registry update
2026-07-17
NCT07282600
Study-wide statusRecruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Listed locations
60
Recruiting locations
60
Registry update
2026-07-17
NCT07321886
Study-wide statusRecruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Listed locations
41
Recruiting locations
41
Registry update
2026-07-17
NCT07353931
Study-wide statusRecruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Listed locations
38
Recruiting locations
34
Registry update
2026-07-17
NCT07369011
Study-wide statusRecruiting

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Listed locations
23
Recruiting locations
23
Registry update
2026-07-17
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United States, or keep Eloralintide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Eloralintide in North America

Eloralintide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Eloralintide is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: Eloralintide Phase 2 study - NCT06230523 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Eloralintide Phase 2 study - NCT06230523

Eloralintide Phase 2 study - NCT06230523 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Eloralintide Phase 2 study - NCT06230523 ↗

Drugs@FDA approved drug database

Drugs@FDA approved drug database is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drugs@FDA approved drug database ↗

Locate a state-licensed online pharmacy

Locate a state-licensed online pharmacy is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Locate a state-licensed online pharmacy ↗
United States / Country guide

United States market context.

A US peptide search can surface prescription drugs, compounded preparations, telehealth offers, and laboratory-research materials in one result set. Federal and state records answer different questions, so no single lookup validates every route.

  • FDA’s BeSafeRx directory sends consumers to each state board’s pharmacy-license database and says an unlisted online pharmacy should not be used.
  • Sections 503A and 503B apply different conditions to compounding from bulk drug substances; FDA updates the underlying lists and policies as substances are evaluated.
  • FDA’s peptide-related bulk-substance page identifies limited information or potential safety concerns for several names that also appear in research and wellness marketing.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Start with the seller class

For an online pharmacy claim, use FDA’s state-license directory to reach the relevant board database and match the business, address, and current license before comparing price.

02

Separate the federal record

Check FDA approval, shortage, outsourcing-facility, and bulk-substance records separately; a state pharmacy license does not make every product or compounding claim federally supported.

03

Keep research outside care

A laboratory-research listing is not a prescription pathway. Compare only like-for-like catalog rows and retain the research-only boundary, source date, shipping claim, and evidence-access label.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
Eloralintide Phase 2 study - NCT06230523ClinicalTrials.gov
02
Drugs@FDA approved drug databaseU.S. Food and Drug Administration
03
Locate a state-licensed online pharmacyU.S. Food and Drug Administration
04
Bulk drug substances used in compoundingU.S. Food and Drug Administration
05
Peptide and other bulk-substance safety risksU.S. Food and Drug Administration
06
Eloralintide study search in United StatesClinicalTrials.gov
07
NCT06143956: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightClinicalTrials.gov
08
NCT07215559: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 DiabetesClinicalTrials.gov
09
NCT07282600: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesClinicalTrials.gov
10
NCT07321886: A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesClinicalTrials.gov
11
NCT07353931: Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightClinicalTrials.gov
12
NCT07369011: A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.